DTL
LYEL icon

Dynamic Technology Lab’s Lyell Immunopharma LYEL Stock Holding History

Dynamic Technology Lab’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-520
Closed -$52K – 1363
2022
Q1 		$52K Buy
+520
New +$63K 0.01% 1037

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
A
Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dynamic Technology Lab's LYEL Position: Q2 2022 in Review

Dynamic Technology Lab sold out of Lyell Immunopharma (LYEL) in Q2 2022, closing a stake of 520 shares — an estimated $52K sold.

Dynamic Technology Lab first reported a position in LYEL in Q1 2022 and held it in 1 quarter. The position peaked at $52K in Q1 2022. 75 funds tracked by Wall St. Rank hold LYEL as of Q2 2022.

  • Dynamic Technology Lab reported no remaining Lyell Immunopharma position as of Q2 2022 after selling out during the quarter.
  • Dynamic Technology Lab sold 520 Lyell Immunopharma shares in Q2 2022, an estimated $52K.
  • Dynamic Technology Lab first reported a position in Lyell Immunopharma in Q1 2022 and held it in 1 quarter.
  • Dynamic Technology Lab's Lyell Immunopharma position peaked at $52K in Q1 2022.
  • 75 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2022.

Based on Dynamic Technology Lab's 13F filing for Q2 2022, filed 12 Aug 2022.